Serum Levels of Free Light Chain before and after Chemotherapy in Primary Systemic AL Amyloidosis-Reference-Cited by-同舟云学术

Serum Levels of Free Light Chain before and after Chemotherapy in Primary Systemic AL Amyloidosis

Published:2005 Issue:5 Volume:44 Page:428-433
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

MATSUDA Masayuki¹,YAMADA Toshiyuki²,GONO Takahisa¹,SHIMOJIMA Yasuhiro¹,ISHII Wataru¹,FUSHIMI Tomohisa¹,SAKASHITA Kazuo³,KOIKE Kenichi³,IKEDA Shu-ichi IKEDA¹

Affiliation:

1. Third Department of Medicine

2. Department of Clinical Pathology, Juntendo University School of Medicine, Tokyo

3. Department of Pediatrics, Shinshu University School of Medicine, Matsumoto

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/44/5/44_5_428/_pdf

Reference13 articles.

1. 1) Buxbaum J. The amyloidoses. in: Rheumatology. 2nd ed. Klippel JH, Dieppe PA, Eds. Mosby, London, 1998: 8.27.1-10.

2. 2) Kyle RA, Gertz MA. Primary systemic amyloidosis. Clinical and laboratory features in 474 cases. Semin Hematol 32: 45-59, 1995.

3. 3) Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 97: 2900-2902, 2001.

4. 4) Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 47: 673-680, 2001.

5. 5) Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48: 1437-1444, 2002.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amyloid neuropathy and autonomic dysfunction;Neurology and Clinical Neuroscience;2022-04-14

2. Serum Free Light Chain Predict Overall Survival and Response to Therapy in Patients with Newly Diagnosed Multiple Myeloma;Clinical Laboratory;2018

3. Serum Free Light Chain Response After 2 Courses of Induction Chemotherapy Predicts Prognosis in Myeloma Patients;Clinical Lymphoma Myeloma and Leukemia;2015-02

4. Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in Patients with Systemic Light Chain Amyloidosis;Internal Medicine;2015

5. Serum-free light-chain assay: clinical utility and limitations;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2014-01-31